LANDOLFO, Santo Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 15.189
EU - Europa 9.294
AS - Asia 5.064
AF - Africa 289
SA - Sud America 114
OC - Oceania 89
Continente sconosciuto - Info sul continente non disponibili 6
Totale 30.045
Nazione #
US - Stati Uniti d'America 14.938
CN - Cina 2.511
IT - Italia 2.175
IE - Irlanda 1.223
SE - Svezia 1.129
DE - Germania 880
SG - Singapore 868
FR - Francia 735
UA - Ucraina 696
FI - Finlandia 626
GB - Regno Unito 563
KR - Corea 541
AT - Austria 349
PL - Polonia 290
VN - Vietnam 246
IN - India 212
CA - Canada 207
SN - Senegal 207
JP - Giappone 204
DK - Danimarca 123
ID - Indonesia 121
NL - Olanda 118
HK - Hong Kong 99
BE - Belgio 97
AU - Australia 79
TW - Taiwan 64
BR - Brasile 52
ES - Italia 46
GR - Grecia 42
RU - Federazione Russa 38
IR - Iran 37
MX - Messico 36
RO - Romania 32
IQ - Iraq 29
IL - Israele 28
SA - Arabia Saudita 26
CH - Svizzera 23
TR - Turchia 23
UG - Uganda 21
CZ - Repubblica Ceca 20
ZA - Sudafrica 19
CO - Colombia 18
NO - Norvegia 17
PK - Pakistan 15
AR - Argentina 13
HR - Croazia 12
SI - Slovenia 12
HU - Ungheria 11
NZ - Nuova Zelanda 10
PH - Filippine 10
EC - Ecuador 9
PE - Perù 9
PT - Portogallo 9
TN - Tunisia 9
CL - Cile 8
KE - Kenya 8
MU - Mauritius 6
MY - Malesia 6
EG - Egitto 5
EU - Europa 5
LU - Lussemburgo 5
PR - Porto Rico 4
QA - Qatar 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
TH - Thailandia 4
BG - Bulgaria 3
BY - Bielorussia 3
EE - Estonia 3
GP - Guadalupe 3
JO - Giordania 3
LK - Sri Lanka 3
MA - Marocco 3
NG - Nigeria 3
SC - Seychelles 3
ZM - Zambia 3
BD - Bangladesh 2
BO - Bolivia 2
GY - Guiana 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
CI - Costa d'Avorio 1
GH - Ghana 1
IS - Islanda 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
ME - Montenegro 1
NP - Nepal 1
SM - San Marino 1
UY - Uruguay 1
UZ - Uzbekistan 1
YE - Yemen 1
Totale 30.045
Città #
Chandler 2.583
Beijing 1.350
Dublin 1.204
Houston 1.089
Fairfield 766
Singapore 646
Jacksonville 587
Ann Arbor 535
Torino 500
Ashburn 488
Villeurbanne 481
Woodbridge 451
Princeton 406
Wilmington 391
Medford 349
Vienna 334
Seattle 315
Columbus 311
Nyköping 289
Dearborn 274
Warsaw 271
Cambridge 264
Pisa 262
Dong Ket 179
Redwood City 174
Boston 165
Guangzhou 159
Milan 151
Fremont 134
Turin 125
Boardman 123
Jakarta 120
Sovicille 115
New York 110
Shanghai 98
Toronto 92
Santa Clara 79
Verona 67
Rome 63
Nanjing 62
Norwalk 62
Los Angeles 58
Brussels 52
Baltimore 51
San Diego 49
Helsinki 48
Taipei 47
Phoenix 45
Piemonte 44
Hefei 43
Washington 41
Kunming 39
Mumbai 39
Philadelphia 38
Tokyo 38
Wuhan 37
Hangzhou 36
Silver Spring 36
Falls Church 35
Lachine 35
Munich 35
London 32
Seongnam 32
Jinan 31
Düsseldorf 29
Chicago 28
San Mateo 27
Hebei 25
Higashiayase 25
Pittsburgh 25
Seoul 25
Maddaloni 24
Ningbo 24
Ottawa 24
Shenyang 24
Berlin 23
New Delhi 22
Rochester 22
Chengdu 21
Novara 21
Hong Kong 20
Siena 20
Galveston 19
Birmingham 18
Jeddah 18
Kampala 18
Lappeenranta 18
Nanchang 18
Des Moines 17
Hanover 17
Orange 17
Tappahannock 17
Utrecht 17
Zhengzhou 17
Fuzhou 16
Melbourne 16
Pune 16
Bogotá 15
Buffalo 15
Central 15
Totale 17.898
Nome #
Distinct Anti-IFI16 and Anti-GP2 Antibodies in Inflammatory Bowel Disease and Their Variation with Infliximab Therapy 435
Prevalence of HPV infection in racial-ethnic subgroups of head and neck cancer patients 390
The human cytomegalovirus tegument protein pp65 (pUL83): a key player in innate immune evasion 382
ANALISI DELLA RISPOSTA IMMUNITARIA INNATA IN CHERATINOCITI UMANI DOPO INFEZIONE CON CITOMEGALOVIRUS . 322
Role of the interferon-inducible gene IFI16 in the etiopathogenesis of systemic autoimmune disorders 313
Up-regulation of the interferon-inducible IFI16 gene by oxidative stress triggers p53 transcriptional activity in endothelial cells 300
Biological relevance of Cytomegalovirus genetic variability in congenitally and postnatally infected children. [*Dell'Oste V, *Landolfo S, co-corresponding authors] 277
Immunohistochemical expression analysis of the human interferon-inducible gene IFI16, a member of the HIN200 family, not restricted to hematopoietic cells. 250
Mislocalization of the interferon inducible protein IFI16 by environmental insults: Implications in autoimmunity 250
The Extracellular IFI16 Protein Propagates Inflammation in Endothelial Cells Via p38 MAPK and NF-κB p65 Activation 249
Human cytomegalovirus productively infects lymphatic endothelial cells and induces a secretome that promotes angiogenesis and lymphangiogenesis through interleukin-6 and granulocyte-macrophage colony-stimulating factor 248
Redistribution of the nuclear protein IFI16 into the cytoplasm of ultraviolet B-exposed keratinocytes as a mechanism of autoantigen processing. 240
The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells 239
Differential expression of HER2, STAT3, SOX2, IFI16 and cell cycle markers during HPV-related head and neck carcinogenesis 237
The proapoptotic activity of the Interferon-inducible gene IFI16 provides new insights into its etiopathogenetic role in autoimmunity. 236
Distinct Roles for Human Cytomegalovirus Immediate Early Proteins IE1 and IE2 in the transcriptional regulation of MICA and PVR/CD155 expression. 229
Peptide-derivatized dendrimers inhibit human cytomegalovirus infection by blocking virus binding to cell surface heparan sulfate. 227
The DNA Cytosine Deaminase APOBEC3G is upregulated during Human Cytomegalovirus infection 225
Cell cycle and viral and immunologic profiles of head and neck squamous cell carcinoma as predictable variables of tumor progression. M. DE ANDREA CO-FIRST AUTHOR 213
Improved detection reveals active β-papillomavirus infection in skin lesions from kidney transplant recipients 210
PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas. 205
A novel role of the interferon-inducible protein IFI16 as inducer of proinflammatory molecules in endothelial cells 186
Modulation of the innate immune response by human cytomegalovirus. [*Dell'Oste V., Landolfo S. co-corresponding authors] 183
Altered patterns of the interferon-inducible gene IFI16 expression in head and neck squamous cell carcinoma: immunohistochemical study including correlation with retinoblastoma protein, human papillomavirus infection and proliferation index 181
In vivo growth inhibition of head and neck squamous cell carcinoma by the Interferon-inducible gene IFI16. M. DE ANDREA CO-FIRST AUTHOR 180
IL GENE INTERFERON-INDUCIBILE IFI16: POTENZIALE FATTORE ANTIVIRALE E MARCATORE DIAGNOSTICO DELLE INFEZIONI DA PAPILLOMAVIRUS UMANI 179
The human Cytomegalovirus tegument protein pp65 (pUL83) dampens interferon-type I production by inactivating the DNA sensor cGAS 179
The Human Cytomegalovirus Tegument Protein pp65 (pUL83) Dampens Type I Interferon Production by Inactivating the DNA Sensor cGAS without Affecting STING [*Biolatti M, Dell'Oste V* co-first authors] 179
The interferon-inducible gene IFI16 secretome of endothelial cells drives the early steps of the inflammatory response 178
Innate Nuclear Sensor IFI16 Translocates into the Cytoplasm during the Early Stage of In Vitro Human Cytomegalovirus Infection and Is Entrapped in the Egressing Virions during the Late Stage. 174
The US16 gene of human cytomegalovirus is equired for efficient viral infection of endothelial and epithelial cells.[Bronzini M.*, Luganini A.* co-first author] 173
HPV18 Persistence Impairs Basal and DNA Ligand-Mediated IFN-β and IFN-λ1 Production through Transcriptional Repression of Multiple Downstream Effectors of Pattern Recognition Receptor Signaling. 169
A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: the interferon-inducible gene IFI16 168
Regulatory Interaction between the Cellular Restriction Factor IFI16 and Viral pp65 (pUL83) Modulates Viral Gene Expression and IFI16 Protein Stability [*Biolatti M, *Dell'Oste V, co-first authors] 168
NUOVO MECCANISMO DI EVASIONE DEL CITOMEGALOVIRUS UMANO DAL FATTORE DI RESTRIZIONE IFI16. 165
Genotypic analysis of HCMV polymorphism in congenital infections to predict the impact of HCMV disease severity in newborns/infants 164
The Nuclear DNA Sensor IFI16 Acts as a Restriction Factor for Human Papillomavirus Replication through Epigenetic Modifications of the Viral Promoters. M. DE ANDREA CO-FIRST AUTHOR 163
The intracellular DNA Sensor IFI16 gene acts as restriction factor for human cytomegalovirus replication [*Gariano GR, *Dell'Oste V*, co-first authors] 162
Citrullination during Human Cytomegalovirus infection: implications for autoimmune diseases 159
Human papillomavirus tumor-infiltrating T-regulatory lymphocytes and P53 codon 72 polymorphisms correlate with clinical staging and prognosis of oropharyngeal cancer 148
CHARACTERIZATION OF POST-TRANSLATIONAL MODIFICATIONS DURING HUMAN CYTOMEGALOVIRUS INFECTION: IMPLICATIONS FOR NOVEL ANTIVIRALS 148
Restriction factors against human CMV 146
Circulating Interferon-Inducible Protein IFI16 Correlates With Clinical and Serological Features in Rheumatoid Arthritis. 145
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer’s disease. 143
Catch me if you can: the arms race between human cytomegalovirus and the innate immune system [Ganna Galitska*, Matteo Biolatti*, equal contribution) 143
Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide. 142
Nuclear DNA sensor IFI16 as circulating protein in autoimmune diseases is a signal of damage that impairs endothelial cells through high-affinity membrane Binding 142
Interferon-α Production by Plasmacytoid Dendritic Cells Is Dispensable for an Effective Anti-Cytomegalovirus Response in Adaptor Protein-3-Deficient Mice. [Del Prete A.*, Luganini A.* co-first author] 140
The absent in melanoma 2-like receptor IFN-inducible protein 16 as an inflammasome regulator in systemic lupus erythematosus: The dark side of sensing microbes 140
Interferon gamma-inducible protein 16 (IFI16) and anti-IFI16 antibodies in primary Sjögren's syndrome: findings in serum and minor salivary glands. 140
Interplay between human cytomegalovirus and intrinsic/innate host responses: a complex bidirectional relationship 138
Proteasomal degradation of herpes simplex virus capsids in macrophages releases DNA to the cytosol for recognition by DNA sensors. 137
The Nuclear DNA Sensor IFI16 Acts as a Restriction Factor for Human Papillomavirus Replication through Epigenetic Modifications of the Viral Promoters 134
[Protein p53 inhibits the activity of the enhancer of the immediate-early genes of murine cytomegalovirus] 133
Evasion strategy of Human Cytomegalovirus from the antiviral activities of APOBEC3G 133
Strigolactone analogs are promising antiviral agents against Herpesviruses 132
Strigolactones as antiviral drugs to inhibit Herpesvirus replication 132
Intrinsic host restriction factors of human cytomegalovirus replication and mechanisms of viral escape 129
[Serum stimulates the transcriptional activity of the enhancer of the immediate-early genes of the murine cytomegalovirus through p21 ras] 126
The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity. [*Biolatti M, *Dell'Oste V, co-first authors] 125
Past and ongoing adaptation of human cytomegalovirus to its host. 124
A Leopard Can Change Its Spots: How HCMV Genetic Variability Impacts Viral Fitness and NK Ligands Immunomodulation 123
IL GENE INTERFERON-INDUCIBILE IFI16: POTENZIALE FATTORE ANTIVIRALE E MARCATORE DIAGNOSTICO DELLE INFEZIONI DA PAPILLOMAVIRUS UMANI 122
Interferon α/β 122
Lack of EVER2 Protein in Two Epidermodysplasia Verruciformis Patients with Skin Cancer Presenting Previously Unreported Homozygous Genetic Deletions in the EVER2 Gene 121
The interferon-inducibel IFI16 gene is a restriction factor for Human cytomegalovirus replication 118
La proteina interferon-inducibile ifi16: fattore di restrizione per la replicazione degli herpesvirus umani 118
Anti-IFI16 antibodies and their relation to disease characteristics in systemic lupus erythematosus 117
Regulatory interaction between the cellular restriction factor IFI16 and viral pp65 (pUL83) modulates viral gene expression and IFI16 protein stability 117
Interferon gamma-inducible protein 16 in primary Sjögren's syndrome: a novel player in disease pathogenesis? 116
IFI16 Impacts Metabolic Reprogramming during Human Cytomegalovirus Infection [*Valentina Dell'Oste, *Matteo Biolatti, co-corresponding authors] 116
IFI16 expression is related to selected transcription factors during B-cell differentiation 114
Relevance of Interferon-Inducible Protein-16 Rather than Anti-Interferon-Inducible Protein-16 Autoantibodies as a Clinical and Pathogenic Biomarker in Primary Sjögren's Syndrome: Comment on the Article by Baer et al. 114
HPV meets APOBEC: New players in head and neck cancer [*Biolatti M, Dell'Oste V* co-last authors]. 112
Trans-activation of the mouse cytomegalovirus immediate early gene enhancer by ras oncogenes 111
The retinoblastoma protein is an essential mediator that links the interferon-inducible 204 gene to cell-cycle regulation. 111
THE ROLE OF ANTI-IFI16 ANTIBODIES IN THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES (IBD) 110
Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity 110
Keratinocyte-specific stat3 heterozygosity impairs development of skin tumors in human papillomavirus 8 transgenic mice 110
IFI16 is a Negative Regulator of Glucose and Cellular Lipid Metabolism during Human Cytomegalovirus Infection 109
Lyt phenotype of T-lymphocytes producing migration inhibitory factor (MIF) in primary murine mixed lymphocyte culture. 108
Modulation of HIV-LTR activity by ras oncogenes. 108
HUMAN CYTOMEGALOVIRUS INFECTION TRIGGERS THE INTERFERON RESPONSE VIA THE DNA SENSOR IFI16 IN HUMAN KERATINOCYTES 107
Early stage IFI16 cytoplasmic translocation and late stage entrapment into egressing virions during HCMV infection 106
Metabolic Games: IFI16-Driven Regulation of Cellular Metabolism upon HCMV Infection 105
A leopard can change its spots: how HCMV genetic variability impacts viral fitness and NK ligands immunomodulation 105
The thymidylate synthase inhibitor ZD1604 potently inhibits murine and human cytomegalovirus replication in quiescent fibroblasts 104
Alpha- and betapapillomavirus E6/E7 genes differentially modulate pro-inflammatory gene expression 102
HPV E7 Oncoprotein Subverts Host Innate Immunity Via SUV39H1-Mediated Epigenetic Silencing of Immune Sensor Genes 102
HSV-1-induced PAD-mediated Citrullination as a New Target for Antiviral Therapy 101
COMPARATIVE ANALYSIS OF HUMAN CYTOMEGALOVIRUS CLINICAL ISOLATES FROM KIDNEY TRANSPLANT RECIPIENTS 101
The IFI16 restriction factor cooperates with HCMV pUL83 to down-regulate UL54 gene expression and viral DNA synthesis 101
The Elk-1 and Serum Response Factor binding sites in the Major Immediate-Early Promoter of the Human Cytomegalovirus are required for efficient viral replication in quiescent cells and compensate for inactivation of the NF-kB sites in proliferating cells [Caposio*, Luganini* co-first author] 101
Activation of the virus-induced IKK/NF-kB signaling axis is critical for the replication of HCMV in quiescent cells 99
Novel antipathogenic peptides = 复合保温防火板. 98
The Ifi 200 genes: an emerging family of IFN-inducible genes 98
Human cytomegalovirus-induced host protein citrullination is crucial for viral replication 98
Alloantigen requirements for nonproliferative activation of t lymphocytes. 97
Human cytomegalovirus stimulates cellular dihydrofolate reductase activity in quiescent cells. 97
New cell-based indicator assays for the detection of human cytomegalovirus infection and screening of inhibitors of viral immediate-early 2 (IE2) protein activity 97
Totale 16.033
Categoria #
all - tutte 86.560
article - articoli 0
book - libri 0
conference - conferenze 23.074
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 109.634


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.382 0 0 0 0 366 1.032 508 268 414 332 236 226
2020/20213.306 293 168 237 205 291 246 331 149 435 339 206 406
2021/20223.328 129 181 208 301 118 104 192 176 103 238 814 764
2022/20236.914 511 298 124 737 825 1.739 372 567 1.106 155 297 183
2023/20242.704 405 421 166 133 206 346 116 147 35 153 217 359
2024/20251.648 137 419 374 629 89 0 0 0 0 0 0 0
Totale 31.052